| Photo Credit: Istockphoto
Apollo Hospitals, Gabriel India and Warren Tea announce the merger and Demerger.
The Apollo Hospitals Enterprise board approved separate lists of omnichannel pharmacies and digital health businesses within 18-21 months as part of a reorganization exercise to devalue. The board of directors of Apollo Healthco, a subsidiary of Apollo Hospitals and Healthcare Major, has granted principle approval for the composite placement scheme. The scheme requires poachers from Omnichannel Pharmaceuticals and digital health businesses. This includes Apollo’s telehealth business and AHL investments (Apollo Healthco Limited) as a new entity. Following Demerger, this scheme defines fusion with new entities in AHL.
The board of directors of Gabriel India Ltd has approved a composite placement scheme involving Gabriel India Limited, Asia Investments Private Ltd, and Anchemco India Pvt Ltd. This scheme approves the award of business of ANCHEMCO (Defrake fluids, defluid, dediaturing fluid, defluid, defluid, defluid, defluid, defluid, defluid, anchemco. PU/PVC-based adhesive) and investments in Dana Anand India Private Ltd, Henkel Anand India Private Limited, Anand Cy Myutec Automotive Private Limited (Demerged Unvertaking). Gabriel issues 1,158 shares of £1 for each 1,000 shares held in AIPL to AIPL shareholders.
The Warrenty Board has approved an arrangement scheme for the company’s proposed merger/arrangement with Maple Hotels & Resorts Ltd., based on the reports of an independent appraiser. The board has approved all shares of Warren Tea and one share of Maple Hotels & Resorts Limited will be issued.
Released on July 1, 2025
